1.62 (-%)
As of Dec 09, 2024
Source:
Bioatla, Inc is a clinical-stage biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
Country | United States |
Headquarters | san diego, california |
Phone Number | ( 858 ) 558-0708 |
Industry | manufacturing |
CEO | Jay M. Short, Ph.D. |
Website | www.bioatla.com |